Tools · Private company
Razor Genomics
Track this companyFree. Adds Razor Genomics to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- 14-Gene Prognostic AssayNon-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Adjuvant ChemotherapyNon-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Radiographic surveillanceNon-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)NA · ACTIVE_NOT_RECRUITING · started Sep 11, 2020ClinicalTrials.gov NCT01817192 · fetched Nov 12, 2026